Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Lymphoma
Clinical trial register · France

Lymphoma Trials in France, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9714 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
9714
Studies in scope
all four open statuses
6038
Recruiting now
open to new participants
1027
Lead sponsors
across recruiting studies
Top sites
Paris 8 Villejuif 6 Nantes 5 Rouen 5 Bordeaux 5

Lymphoma trials in France

20 of 9714 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Virus-associated Tumour Microenvironment
NCT06471296Lymphoma, Cancers of the Lung, Cancer Anal Canal
Assistance Publique - Hôpitaux de Paris
Observational
150
Paris
2026-05-05
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
65
Nice, Nantes, Pierre-Bénite, Dijon, Lille, Marseille, Montpellier, Paris
2025-11-06
Recruiting
ITM Solucin GmbH
Phase 1
20
Marseille, Villejuif
2025-09-26
Recruiting
SecuraBio
Phase 3
124
Rouen, Villejuif, Caen, Clermont-Ferrand, Montpellier, Nantes, Paris, Pessac
2025-05-19
Recruiting
University Hospital, Angers
Not applicable
2,224
Amiens, Angers, Besançon, Brest, Nancy, Nantes, Poitiers, Saint-Etienne
2025-04-10
Recruiting
RAT-HEMATO : Return to Work After Malignant Hemopathy
NCT06262789Leukemia, Lymphoma, Multiple Myeloma
University Hospital, Angers
Not applicable
264
Angers, Brest, Caen, Cholet, Montivilliers, Morlaix, Rennes, Rouen
2024-09-27
Recruiting
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
NCT06137144Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Peripheral T-cell Lymphoma (PTCL)
AstraZeneca
Phase 1/2
161
Créteil, Dijon, Lille, Pierre-Bénite, Villejuif
2024-01-23
Recruiting
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
NCT05751798Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)
OSE Immunotherapeutics
Phase 1/2
41
Lyon, Paris, Rennes, Saint-Herblain, Toulouse, Villejuif
2022-12-20
Recruiting
Centre Leon Berard
Not applicable
214
Lyon
2022-11-29
Recruiting
REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs
NCT05223413Anthracycline-induced Cardiac Toxicity, Lymphoma
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Not applicable
608
Montivilliers, Rouen
2022-01-18
Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
NCT04094610Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors
Turning Point Therapeutics, Inc.
Phase 1/2
75
Lyon, Angers, Bordeaux, Marseille, Nantes, Paris, Villejuif
2020-03-12
Active, closed
The Lymphoma Academic Research Organisation
Phase 1/2
214
Clermont-Ferrand, Argenteuil, Avignon, Besançon, Bordeaux, Chambéry, Créteil, Dijon
2016-10
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Villejuif, Pierre-Bénite, Bordeaux, Nice, Rouen, Toulouse, Tours
2015-07-14
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
370
Paris
2015-03-19
Recruiting
AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
NCT02595255Fertility Preservation, Lymphoma, Pediatrics Cancer, Gonadotropin-releasing Hormone Agonist
Erasme University Hospital
Observational
275
Lille
2014-04
Recruiting
Institut Paoli-Calmettes
Observational
16,000
Marseille
2000-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
1,649
Ambilly, Annecy, Aulnay-sous-Bois, Avignon, Bayonne, Besançon, Béziers, Bordeaux
1998-10
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
615
Bordeaux, Caen, Compiègne, Dijon, Lyon, Nice, Paris, Pierre-Bénite
1989-09
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-france/condition/lymphoma

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,714 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies listing the condition Lymphoma.

How many Lymphoma trials are recruiting in France?

15 of the 20 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lymphoma), 20 studies
PhaseStudiesRecruitingShare
Phase 1/26430%
Not applicable4420%
Phase 34220%
Observational3315%
Phase 22110%
Phase 1115%

Most active sponsors

Lead sponsors with the most studies (Lymphoma)
Lead sponsorStudiesRecruiting
European Organisation for Research and Treatment of Cancer - EORTC20
Hoffmann-La Roche21
University Hospital, Angers22
Assistance Publique - Hôpitaux de Paris11
AstraZeneca11
Centre Leon Berard11
Erasme University Hospital11
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III11
Institut Paoli-Calmettes11
ITM Solucin GmbH11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.